ArticleEuropean journal of neurology2026

Personalised Anti-CD20 Retreatment in Multiple Sclerosis: Precision Medicine or Precision Pharmacology?

Klaus SchmiererPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.